Taken together, these findings strongly suggest that targeting HA/CD44-mediated JNK/c-Jun signaling pathways and miR-21 function may provide new drug targets to sensitize tumor cell apoptosis/death and overcome chemotherapy resistance in MDA-MB-468 breast tumor cells. The gene discussed is JUN; the disease is breast neoplasm.